Mavoglurant Reduces Cocaine Use in Patients with Cocaine Use Disorder in a Phase 2 Clinical Trial.

Baltazar Gomez-Mancilla,Kenneth M Dürsteler,Marc Vogel,Marcus Herdener,Marta Torrens, Bartolomé P Gálvez,Antoni Gual, Ricardo M Corral, Enrique I Kuper, Daniel L Mosca, Swati Dumitras,Nicole Pezous, Maria Berkheimer, Ela Walker,Fabrizio Gasparini, Jang-Ho Cha, Ricardo Dolmetsch

Science translational medicine（2025）

Cited 0|Views2

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined